卒中后癫痫患者癫痫复发对1年功能结局和死亡率的影响
本研究为多中心前瞻性观察队列研究,纳入日本8家医院211例首次发作的卒中后癫痫患者,随访至少1年。1年内50例(23.7%)出现癫痫复发,25例(11.8%)功能下降,20例(9.5%)死亡。癫痫复发与功能下降显著相关(校正OR 3.26,95%CI 1.27-8.36,p=0.01),但与死亡率无关(OR 0.79,95%CI 0.25-2.48,p=0.68)。
要点
- 卒中后癫痫患者1年功能结局和死亡率较差,11.8%功能下降,9.5%死亡。
- 癫痫复发与1年功能下降显著相关(校正OR 3.26,95%CI 1.27-8.36)。
- 癫痫复发与死亡率无显著关联(OR 0.79,95%CI 0.25-2.48)。
核心结论
- 卒中后癫痫患者1年功能结局和死亡率较差,癫痫复发与功能结局显著相关,但与死亡率无关。
- 作者认为需要进一步研究以确定早期充分的抗癫痫治疗能否预防卒中后癫痫患者的功能恶化。
研究设计与样本
- 本研究为卒中后癫痫预后研究的一部分,是一项多中心前瞻性观察队列研究,在日本8家医院随访至少1年。
- 纳入392例卒中后癫痫患者(末次症状性卒中发作后超过7天出现至少1次无诱因癫痫发作),本分析仅纳入首次发作的卒中后癫痫患者211例,中位年龄75岁,中位mRS评分3分。
主要发现
- 1年时50例(23.7%)出现癫痫复发,25例(11.8%)功能下降,20例(9.5%)死亡。
- 大多数患者死于肺炎或心脏病(各7例),未发现与癫痫复发直接相关的已知死亡原因。
- 癫痫复发与功能下降显著相关(OR 2.96,95%CI 1.25-7.03,p=0.01),校正潜在混杂因素后仍显著(校正OR 3.26,95%CI 1.27-8.36,p=0.01),但与死亡率无关(OR 0.79,95%CI 0.25-2.48,p=0.68)。
- 癫痫复发次数越多,功能下降比例越高:无复发、1次复发、2次及以上复发患者的功能下降比例分别为8.7%、20.6%、28.6%(p=0.006)。
关键数值与推荐
- 功能下降定义为1年时改良Rankin量表(mRS)评分较基线增加,排除死亡。
- 卒中后癫痫定义为末次症状性卒中发作后超过7天出现至少1次无诱因癫痫发作。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The functional outcome and mortality of patients with poststroke epilepsy (PSE) have not been assessed in a prospective study. Previous reports have suggested that patients with PSE may suffer from prolonged functional deterioration after a seizure. In this study, we prospectively investigated the functional outcome and mortality of patients with PSE and analyzed the effect of seizure recurrence on the outcomes. METHODS: This is part of the Prognosis of Post-Stroke Epilepsy study, a multicenter, prospective observational cohort study, where 392 patients with PSE (at least 1 unprovoked seizure more than 7 days after the onset of the last symptomatic stroke) were followed for at least 1 year at 8 hospitals in Japan. This study included only PSE patients with a first-ever seizure and assessed their functional decline and mortality at 1 year. Functional decline was defined as an increase in modified Rankin Scale (mRS) score at 1 year compared with baseline, excluding death. The associations between the seizure recurrence and the outcomes were analyzed statistically. RESULTS: A total of 211 patients (median age of 75 years; median mRS score of 3) were identified. At 1 year, 50 patients (23.7%) experienced seizure recurrence. Regarding outcomes, 25 patients (11.8%) demonstrated functional decline and 20 (9.5%) had died. Most patients died of pneumonia or cardiac disease (7 patients each), and no known causes of death were directly related to recurrent seizures. Seizure recurrence was significantly associated with functional decline (odds ratio [OR] 2.96, 95% CI 1.25-7.03, p = 0.01), even after adjusting for potential confounders (adjusted OR 3.26, 95% CI 1.27-8.36, p = 0.01), but not with mortality (OR 0.79, 95% CI 0.25-2.48, p = 0.68). Moreover, there was a significant trend where patients with more recurrent seizures were more likely to have functional decline (8.7%, 20.6%, and 28.6% in none, 1, and 2 or more recurrent seizures, respectively; p = 0.006). DISCUSSION: One-year functional outcome and mortality of patients with PSE were poor. Seizure recurrence was significantly associated with functional outcome, but not with mortality. Further studies are needed to ascertain whether early and adequate antiseizure treatment can prevent the functional deterioration of patients with PSE.
引用
- Yoshimura H, Tanaka T, Fukuma K, et al. Impact of Seizure Recurrence on 1-Year Functional Outcome and Mortality in Patients With Poststroke Epilepsy. Neurology. 2022. PMID: 35508394. doi:10.1212/WNL.0000000000200609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。